Latest news
Kura Oncology Announces Publication in Blood Highlighting Ziftomenib’s Differentiated Binding Profile and Preclinical Activity - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 12:42:49 GMTKura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswireGlobeNewswire · Fri, 07 Aug 2026 11:30:00 GMTKura Oncology to Report Second Quarter Financial Results - GlobeNewswireGlobeNewswire · Wed, 05 Aug 2026 11:30:00 GMT